How to Get Opsumit (Macitentan) Covered by Aetna in Georgia: Prior Authorization Guide & Appeal Scripts
Answer Box: Quick Path to Opsumit Coverage in Georgia
To get Opsumit (macitentan) covered by Aetna in Georgia: Submit prior authorization with PAH specialist documentation, pregnancy testing compliance (for females), and ICD-10 codes I27.0 or I27.21. Use HCPCS J3490 with NDC 66215-501-15/30. If denied, file internal appeal within 180 days, then external review with Georgia DOI within 60 days of final denial. Start today: Call Aetna at the number on your member card to confirm PA requirements and obtain forms.
Table of Contents
- Coverage Requirements Overview
- Prior Authorization Process
- Essential Documentation Checklist
- Coding That Gets Approved
- Common Denial Reasons & Solutions
- Georgia Appeal Process
- Cost Assistance Options
- When to Contact Georgia Regulators
- FAQ
Coverage Requirements Overview
Opsumit (macitentan) requires prior authorization from Aetna CVS Health for all plans. This specialty medication for pulmonary arterial hypertension (PAH) costs in the five-figure range annually and is dispensed through CVS Specialty or other contracted specialty pharmacies.
Coverage at a Glance
| Requirement | What It Means | Source |
|---|---|---|
| Prior Authorization | Required for all plans | Aetna Precertification List |
| Specialty Pharmacy | CVS Specialty distribution only | CVS Specialty Enrollment |
| Pregnancy Testing | Monthly for females of reproductive potential | FDA Label |
| PAH Specialist | Diagnosis and prescription from pulmonary specialist | Aetna Policy (verify current version) |
| Functional Class | WHO/NYHA Class II-IV documentation | Clinical requirement |
Prior Authorization Process
Aetna processes over 95% of prior authorizations within 24 hours, but specialty medications like Opsumit often require additional clinical review. Submit requests at least two weeks in advance to avoid delays.
Step-by-Step: Fastest Path to Approval
- Confirm Coverage (Patient/Clinic): Call Aetna member services to verify current PA requirements and obtain pre-authorization forms.
- Gather Documentation (Clinic): Collect PAH specialist notes, echocardiogram results, functional class assessment, and pregnancy testing records.
- Submit PA Request (Clinic): Use Aetna's Availity portal or EMR integration with complete clinical documentation.
- Track Status (Patient/Clinic): Monitor approval status through provider portal; Aetna typically responds within 30-45 days for standard requests.
- Request Peer-to-Peer (If needed): If initial review is unfavorable, request physician-to-physician discussion before formal denial.
- Enroll in Specialty Pharmacy (Patient): Complete CVS Specialty enrollment once approved.
- Coordinate REMS Compliance (Patient): While formal REMS ended in 2025, pregnancy testing and contraception requirements remain under FDA labeling.
Essential Documentation Checklist
Clinician Corner: Medical Necessity Letter Components
Your medical necessity letter should include these evidence-backed elements:
Clinical Presentation:
- WHO Group 1 PAH diagnosis with specific etiology (idiopathic, heritable, associated)
- Current WHO/NYHA functional class (II-IV typically required)
- Hemodynamic data from right heart catheterization
- 6-minute walk distance and trends
Prior Therapies:
- Previous PAH treatments tried and outcomes
- Reasons for discontinuation (inefficacy, intolerance, contraindications)
- Current combination therapy rationale
Treatment Plan:
- Target dose (10 mg once daily)
- Monitoring plan (liver function, hemoglobin)
- Expected outcomes and goals
Supporting Evidence:
- Reference FDA-approved indication for PAH
- Cite relevant guidelines (ESC/ERS, AHA/ACC, CHEST)
- Include contraindications to alternative ERAs
What to Gather Before You Start
- Insurance Information: Member ID, group number, provider network status
- Clinical Records: PAH specialist notes, right heart catheterization report, echocardiogram
- Lab Results: Liver function tests, pregnancy test results (if applicable)
- Prior Authorization: Previous denials or approvals for PAH medications
- Prescription Details: Exact dosing, quantity, days supply
Coding That Gets Approved
Proper coding is essential for clean claims and PA approval. Use these verified codes for Opsumit coverage:
ICD-10 Diagnosis Codes
- I27.0: Primary pulmonary hypertension (idiopathic PAH)
- I27.21: Secondary pulmonary arterial hypertension
When coding secondary PAH, also include the underlying condition (connective tissue disease, congenital heart disease, etc.).
HCPCS and NDC Codes
- HCPCS: J3490 (Unclassified drugs)
- NDC Codes: 66215-501-15 (30-tablet bottle), 66215-501-30 (100-tablet bottle)
- Units: Bill per tablet (typically 30 units for 30-day supply)
Medical vs. Pharmacy Benefit
Opsumit is typically covered under the pharmacy benefit as an oral specialty medication. However, some plans may cover it under medical benefit if administered in a clinical setting. Verify benefit structure with Aetna before submitting claims.
Common Denial Reasons & Solutions
| Denial Reason | How to Overturn |
|---|---|
| "Not medically necessary" | Submit functional class documentation showing Class II-IV symptoms with specialist attestation |
| "Experimental/Investigational" | Provide FDA approval documentation and indication-specific evidence |
| "Step therapy required" | Document prior failures/intolerances to ambrisentan, bosentan, or other ERAs with clinical notes |
| "Non-formulary" | Request formulary exception with medical necessity justification and cost-effectiveness data |
| "REMS non-compliance" | Provide pregnancy testing records and contraception documentation per current FDA labeling |
| "Quantity limits exceeded" | Justify dose/frequency with clinical rationale and specialist recommendation |
Georgia Appeal Process
Georgia provides robust consumer protections for insurance denials. You have multiple levels of review available.
Internal Appeals with Aetna
Timeline: 180 days from denial date to file appeal Processing Time: 30 calendar days (standard), 72 hours (expedited) How to File: Submit through Aetna provider portal or member services
External Review in Georgia
If Aetna upholds the denial after internal appeal, you can request external review through the Georgia Department of Insurance.
Key Deadlines: 60 days from final internal denial to request external review Cost: Free to consumers Timeline: 30 business days (standard), 72 hours (expedited/urgent)
How to Request:
- Contact Georgia DOI Consumer Services at 1-800-656-2298
- Submit external review application (available on DOI website)
- Include all denial letters, medical records, and supporting documentation
Note: Georgia allows concurrent external review with expedited internal appeals for urgent situations.
Patient Scripts for Appeals
Script for Aetna Member Services: "I'm calling to appeal the denial of Opsumit for my pulmonary arterial hypertension. The denial letter is dated [date] and references [denial reason]. I need to understand the specific criteria not met and request an expedited peer-to-peer review with my PAH specialist. Can you provide the appeals form and fax number?"
Script for Peer-to-Peer Request: "We're requesting a physician-to-physician discussion regarding the Opsumit denial for [patient name]. Dr. [specialist] is available [days/times] and can provide additional clinical context about the patient's functional class deterioration and prior therapy failures. What's the process to schedule this review?"
Cost Assistance Options
Opsumit's high cost makes financial assistance crucial for many patients:
Manufacturer Support:
- Janssen CarePath savings program
- Income-based patient assistance programs
- Copay reduction cards (commercial insurance only)
Foundation Grants:
- Patient Access Network (PAN) Foundation
- HealthWell Foundation
- Pulmonary Hypertension Association support programs
State Resources:
- Georgia's limited Medicaid expansion may cover eligible patients
- Pharmaceutical assistance programs through Georgia Department of Community Health
When to Contact Georgia Regulators
Contact the Georgia Department of Insurance if:
- Aetna doesn't respond within required timeframes
- You believe the denial violates Georgia insurance law
- External review recommendations aren't implemented
Georgia DOI Contact:
- Phone: 1-800-656-2298
- Online: Insurance Complaint Form
- Address: 2 Martin Luther King Jr. Drive, Atlanta, GA 30334
For Medicaid appeals, contact the Georgia Department of Community Health fair hearing process instead.
FAQ
How long does Aetna prior authorization take for Opsumit in Georgia? Standard PA decisions are made within 30-45 days. Aetna approves over 95% of prior authorizations within 24 hours, but specialty medications often require clinical review extending the timeline.
What if Opsumit is non-formulary on my Aetna plan? Request a formulary exception with medical necessity documentation. Include evidence that formulary alternatives are contraindicated, ineffective, or cause intolerable side effects.
Can I request an expedited appeal in Georgia? Yes. Both Aetna internal appeals and Georgia external reviews offer expedited processing (72 hours) for urgent medical situations where delays could cause serious harm.
Does step therapy apply if I've failed PAH medications outside Georgia? Prior therapy failures from other states count toward step therapy requirements. Provide documentation of previous treatments, dates, outcomes, and reasons for discontinuation.
What pregnancy testing is required for Opsumit coverage? Females of reproductive potential need negative pregnancy tests before starting treatment, monthly during therapy, and for one month after discontinuation, even though formal REMS ended in 2025.
How do I find a PAH specialist in Georgia for Opsumit prescribing? Contact major medical centers like Emory, Georgia Health Sciences, or use the Pulmonary Hypertension Association provider directory to locate certified PAH specialists.
What should I do if CVS Specialty denies my Opsumit prescription? Specialty pharmacy denials are often related to insurance authorization status. Verify PA approval with Aetna first, then contact CVS Specialty patient services to resolve enrollment or shipping issues.
Can I appeal to Georgia if I have a Medicare Advantage plan through Aetna? Medicare Advantage appeals follow federal CMS procedures, not Georgia state processes. Contact 1-800-MEDICARE for Medicare-specific appeal rights and timelines.
About Counterforce Health: Counterforce Health specializes in turning insurance denials into successful appeals for patients, clinicians, and specialty pharmacies. The platform analyzes denial letters, identifies specific coverage criteria, and drafts evidence-backed appeals that address payer requirements point-by-point. For complex cases like Opsumit denials, Counterforce Health helps ensure appeals include the right clinical documentation, coding, and regulatory citations to maximize approval chances.
From our advocates: "We've seen Opsumit denials overturned most successfully when the appeal directly addresses functional class documentation and prior ERA failures with specific dates and clinical outcomes. Generic 'patient needs this medication' letters rarely succeed, but detailed specialist attestations about disease progression and alternative therapy contraindications often do."
Sources & Further Reading
- Aetna Prior Authorization Lists and Procedures
- Opsumit FDA Prescribing Information
- CVS Specialty Opsumit Enrollment Form
- Georgia Department of Insurance Consumer Services
- Aetna Appeals and Disputes Process
- Macitentan REMS Program Update
Disclaimer: This guide provides general information about insurance coverage and appeals processes. It is not medical or legal advice. Coverage decisions depend on individual plan terms, medical circumstances, and current policies. Always consult with your healthcare provider about treatment decisions and verify current requirements with your insurance company. For legal assistance with appeals, consider consulting a healthcare attorney familiar with Georgia insurance law.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.